A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension
Clinical trial NCT04140279 · WITHDRAWN
Trial details
- NCT number
- NCT04140279
- Sponsor
- Bausch & Lomb Incorporated
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2023-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.